Dasabuvir/ombitasvir/paritaprevir/ritonavir/sorafenibVarious toxicities: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1730卷 / 1期

关键词：

D O I：

10.1007/s40278-018-55013-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：113 / 113

相关论文

共 50 条

[1] Dasabuvir/methadone/ombitasvir/paritaprevir/ritonavir interactionVarious toxicities: case report
Reactions Weekly, 2016, 1628 (1) : 123 - 123
[2] Dasabuvir/ombitasvir/paritaprevir/ritonavirVarious toxicities: 5 case reports
Reactions Weekly, 2022, 1911 (1) : 168 - 168
[3] Dasabuvir/ombitasvir/paritaprevir/ritonavirVarious toxicities: 5 case reports
Reactions Weekly, 2017, 1669 (1) : 101 - 101
[4] Dasabuvir/ombitasvir/paritaprevir/ritonavirVarious toxicities: 2 case reports
Reactions Weekly, 2019, 1778 (1) : 164 - 164
[5] Dasabuvir/ombitasvir/paritaprevir/ritonavir/ribavirinGastrointestinal bleeding and bleeding: 2 case reports
Reactions Weekly, 2022, 1914 (1) : 180 - 180
[6] Paritaprevir/ritonavir/ombitasvir plus dasabuvir
不详
AUSTRALIAN PRESCRIBER, 2016, 39 (04) : 141 - 143
[7] Ombitasvir/paritaprevir/ritonavir/quetiapineVarious toxicities: case report
Reactions Weekly, 2019, 1770 (1) : 317 - 317
[8] Dasabuvir/ombitasvir/paritaprevir/ritonavir/ribavirinElevation of the liver enzymes: case report
Reactions Weekly, 2016, 1630 (1) : 85 - 85
[9] Dasabuvir/ombitasvir/paritaprevir/ritonavirHepatitis B reactivation: 2 case reports
Reactions Weekly, 2020, 1829 (1) : 141 - 141
[10] OMBITASVIR/PARITAPREVIR/RITONAVIR PLUS DASABUVIR TREATMENT EXPERIENCE IN HCV PATIENTS
Bayan, Kadim
Celen, Mustafa Kemal
Dal, Tuba
Ayaz, Celal
Tekin, Recep
Akdemir, Irem
Sari, Tugba
Gunal, Ozgur
Efe, Savas Cumali
ACTA MEDICA MEDITERRANEA, 2018, 34 (01): : 71 - 75

← 1 2 3 4 5 →